Immunome, Inc.

IMNMNASDAQ • USD
18.57 USD
↘ 0.20 (1.06%)🟢PRE MARKET (AS OF 07:24 AM EST)
🟢Market: OPEN

IMNM is currently priced at $18.57. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. IMNM is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$18.70
High?$18.83
Low?$18.38
Prev. Close?$18.77
Volume?1.6K
Avg. Volume?1.5M
VWAP?$18.48
Rel. Volume?0.00x
Bid / Ask
Bid?$15.30 × 100
Ask?$21.98 × 100
Spread?$6.68
Midpoint?$18.64
Valuation & Ratios
Market Cap?2.2B
Shares Out?118.1M
Float?101.2M
Float %?89.1%
P/E Ratio?N/A
P/B Ratio?4.88
EPS?-$2.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Employees
177
Market Cap
2.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-02
Address
18702 N. CREEK PARKWAY
BOTHELL, WA 98011
Phone: 610-321-3700
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
24
Piotroski F-Score?0/9Weak
Altman Z-Score?22.43Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?15.99%High
Short Interest?16.2M
Days to Cover?12.8
Free Float101.2M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?11.66Strong
Quick Ratio?11.66Strong
Cash Ratio?5.20Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
38
4.88FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-62.2%WEAK▾
ROA?
S&P
3
-55.9%WEAK▾
Cash Flow & Enterprise
FCF?$-238700000
Enterprise Value?$2.0B
Fundamentals ratios updated end of day